Evidence map›Paper›PMID 30175643›Full record

ArticleInquiry : a journal of medical care organization, provision and financing

Financial Impact of Incentive Spirometry.

Adam E M Eltorai, Grayson L Baird, Joshua Pangborn, Ashley Szabo Eltorai, Valentin Antoci, Katherine Paquette, Kevin Connors, Jacqueline Barbaria, Kimberly J Smeals, Barbara Riley and 6 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Inquiry : a journal of medical care organization, provision and financing. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07728214 (Reminder-enhanced Incentive Spirometry Evaluation), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07728214 nanot yet recruitingnot on this map

Reminder-enhanced Incentive Spirometry Evaluation (RISE)

TypeinterventionalSponsorUniversity of Colorado, DenverRan2026 to 2029Enrolled88ConditionsHypoxemiaArmsAlarms ON
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Incentive Spirometer in COVID-19: A Systematic Review.Journal of clinical medicine · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Adam E M Eltorai1 The Warren Alpert Medical School of Brown University, Providence, RI, USA.ORCID 0000-0001-5749-6631
Grayson L Baird1 The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Joshua Pangborn1 The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Ashley Szabo Eltorai3 Yale University, New Haven, CT, USA.
Valentin Antoci1 The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Katherine Paquette4 The University of Rhode Island, Providence, USA.
Kevin Connors2 Rhode Island Hospital, Providence, USA.
Jacqueline Barbaria2 Rhode Island Hospital, Providence, USA.
Kimberly J Smeals2 Rhode Island Hospital, Providence, USA.
Barbara Riley2 Rhode Island Hospital, Providence, USA.
Shyam A Patel1 The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Saurabh Agarwal1 The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Terrance T Healey1 The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Corey E Ventetuolo1 The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Frank W Sellke1 The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Alan H Daniels1 The Warren Alpert Medical School of Brown University, Providence, RI, USA.
Providence College · USBrown University · USUniversity of Rhode Island · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite largely unproven clinical effectiveness, incentive spirometry (IS) is widely used in an effort to reduce postoperative pulmonary complications. The objective of the study is to evaluate the financial impact of implementing IS. The amount of time nurses and RTs spend each day doing IS-related activities was assessed utilizing an online survey distributed to the relevant national nursing and respiratory therapists (RT) societies along with questionnaire that was prospectively collected every day for 4 weeks at a single 10-bed cardiothoracic surgery step-down unit. Cost of RT time to teach IS use to patients and cost of nurse time spent reeducating and reminding patients to use IS were used to calculate IS implementation cost estimates per patient. Per-patient cost of IS implementation ranged from $65.30 to $240.96 for a mean 9-day step-down stay. For the 566 patients who stayed in the 10-bed step-down in 2016, the total estimated cost of implementing IS ranged from $36 959.80 to $136 383.36. Using national survey workload data, per-patient cost of IS implementation costed $107.36 (95% confidence interval [CI], $97.88-$116.98) for a hospital stay of 4.5 days. For the 9.7 million inpatient surgeries performed annually in the United States, the total annual cost of implementing postoperative IS is estimated to be $1.04 billion (95% CI, $949.4 million-$1.13 billion). The cost of implementing IS is substantial. Further efficacy studies are necessary to determine whether the cost is justifiable.

Indexed as

Cost-Benefit AnalysisMotivationFemaleHealth Care CostsHumansInternetLength of StayMaleNursing Staff, HospitalPostoperative ComplicationsRespiratory TherapySpirometrySurveys and QuestionnairesUnited Stateshealth care costsincentive spirometryinpatientslength of staymotivationnursingpostoperative periodrespiratory function testsrespiratory therapyspirometrysurveys and questionnairestreatment outcomeworkload

Identifiers

PMID30175643
PMCPMC6122234
OpenAlexW2891333314

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.